CRISPR Therapeutics AG (CRSP): Weighted Average Diluted Shares
89.93M
Year ended 2025-12-31
+5.0%
3-year compound annual growth
+6.4%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 89.93M | +6.6% | 2026-02-12, From 2025-01-01 |
| 2024-12-31 | 84.36M | +6.5% | 2026-02-12, From 2024-01-01 |
| 2023-12-31 | 79.22M | +1.9% | 2026-02-12, From 2023-01-01 |
| 2022-12-31 | 77.75M | -3.3% | 2025-02-11, From 2022-01-01 |
| 2021-12-31 | 80.39M | +21.9% | 2024-02-21, From 2021-01-01 |
| 2020-12-31 | 65.95M | +15.8% | 2023-02-21, From 2020-01-01 |
| 2019-12-31 | 56.93M | +18.7% | 2022-02-15, From 2019-01-01 |
| 2018-12-31 | 47.96M | +19.7% | 2021-02-16, From 2018-01-01 |
| 2017-12-31 | 40.06M | n/a | 2020-02-12, From 2017-01-01 |